Palivizumab (Anti-RSV-F)

Ask supplier a question | View on supplier's website

Palivizumab (Anti-RSV-F) is a humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylactic application in respiratory syncytial virus infections. MW : 145.5 kD.

Supplier	Selleck Chemicals
Product #	A2364
Sku #	A2364-1mg*5
Pricing	1mg*5, $790.00

Feedback